Ellen Burgess (P Rossing, Peter Rossing)

Publication Activity (10 Years)

Years Active: 2017-2023
Publications (10 Years): 95

Top Venues

Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association

University of Copenhagen

This page only lists publications with an associated author ORCID identifier.

Affiliation History

University of Copenhagen May 1o 2012

Denmark

Professor :: department of clinical medicine

Publications

Roderick C Slieker, Louise A Donnelly, Elina Akalestou, Livia Lopez-Noriega, Rana Melhem, Ayşim Güneş, Frederic Abou Azar, Alexander Efanov, Eleni Georgiadou, Hermine Muniangi-Muhitu, Mahsa Sheikh, Giuseppe N Giordano, Mikael Åkerlund, Emma Ahlqvist, Ashfaq Ali, Karina Banasik, Soren Brunak, Marko Barovic, Gerard A Bouland, Frédéric Burdet, Mickaël Canouil, Iulian Dragan, Petra J M Elders, Céline Fernandez, Andreas Festa, Hugo Fitipaldi, Phillippe Froguel, Valborg Gudmundsdottir, Vilmundur G Gudnason, Mathias J Gerl, Amber A van der Heijden, Lori L Jennings, Michael K Hansen, Min Kim, Isabelle Leclerc, Christian Klose, Dmitry Kuznetsov, Dina Mansour Aly, Florence Mehl, Diana Marek, Olle Melander, Anne Niknejad, Filip Ottosson, Imre Pavo, Kevin Duffin, Samreen K Syed, Janice L Shaw, Over Cabrera, Timothy J Pullen, Kai Simons, Michele Solimena, Tommi Suvitaival, Asger Wretlind, Ellen Burgess, Valeriya Lyssenko, Cristina Legido Quigley, Leif C Groop, Bernard Thorens, Paul W Franks, Gareth E Lim, Jennifer L Estall, Mark Ibberson, Joline Wilhelma Johanna Beulens, Leen M 't Hart, Ewan R Pearson, Guy A Rutter
Identification of biomarkers for glycaemic deterioration in type 2 diabetes. Nature communications 14 (1) (2023)
Christina Gjerlev Poulsen, Daniel G K Rasmussen, Federica Genovese, Tine W Hansen, Signe Holm Nielsen, Henrik Reinhard, Bernt Johan von Scholten, Peter K Jacobsen, Hans-Henrik Parving, Morten Asser Karsdal, Ellen Burgess, Marie Frimodt-Møller
Marker for kidney fibrosis is associated with inflammation and deterioration of kidney function in people with type 2 diabetes and microalbuminuria. PloS one 18 (3) (2023)
Christina Gjerlev Poulsen, Daniel G K Rasmussen, Federica Genovese, Tine W Hansen, Signe Holm Nielsen, Henrik Reinhard, Bernt Johan von Scholten, Peter K Jacobsen, Hans-Henrik Parving, Morten Asser Karsdal, Ellen Burgess, Marie Frimodt-Møller
Marker for kidney fibrosis is associated with inflammation and deterioration of kidney function in people with type 2 diabetes and microalbuminuria. PloS one 18 (3) (2023)
Nikolaos Perakakis, Stefan R Bornstein, Andreas L Birkenfeld, Andreas Linkermann, Münevver Demir, Stefan D Anker, Gerasimos Filippatos, Bertram Pitt, Ellen Burgess, Luis M Ruilope, Peter Kolkhof, Robert Lawatscheck, Charlie Scott, George L Bakris, null null
Efficacy of finerenone in patients with type 2 diabetes, chronic kidney disease and altered markers of liver steatosis and fibrosis: A FIDELITY subgroup analysis. Diabetes, obesity & metabolism (2023)
Niels Søndergaard Heinrich, Rune Ploegstra Pedersen, Mark Bitsch Vestergaard, Ulrich Lindberg, Ulrik Bjørn Andersen, Bryan Haddock, Tine Willum Hansen, Alessia Fornoni, Henrik Bo Wiberg Larsson, Ellen Burgess
Evaluation of the effects of ezetimibe on albuminuria and kidney fat in individuals with type 2 diabetes and chronic kidney disease. Diabetes, obesity & metabolism (2023)
Jens Christian Laursen, Viktor Rotbain Curovic, Marjolein Y A M Kroonen, Niels Jongs, Emilie H Zobel, Tine Willum Hansen, Marie Frimodt-Møller, Gozewijn D Laverman, Adriaan Kooy, Frederik Persson, Hiddo J Lambers Heerspink, Christian Stevns Hansen, Ellen Burgess
Effects of baricitinib, empagliflozin, linagliptin and telmisartan on cardiovascular autonomic neuropathy in type 1 diabetes: An exploratory, randomized, open-label, crossover trial. Diabetes, obesity & metabolism (2023)
Taha Sen, Viktor Rotbain Curovic, Niels Jongs, Gozewijn D Laverman, Adriaan Kooy, Frederik Persson, Ellen Burgess, Hiddo J Lambers Heerspink
Effects of albuminuria-lowering treatments on inflammation markers: A post hoc analysis from the ROTATE trials. Diabetes, obesity & metabolism (2023)
Suvanjaa Sivalingam, Victor Soendergaard Wasehuus, Viktor Rotbain Curovic, Martin Baek Blond, Tine Willum Hansen, Frederik Persson, Ellen Burgess
Albuminuria-lowering effect of adding semaglutide on top of empagliflozin in individuals with type 2 diabetes: A randomized and placebo-controlled study. Diabetes, obesity & metabolism (2023)
Elisabeth Buur Stougaard, Ellen Burgess, Dorte Vistisen, Phillip Banks, Manon Girard, Michael J Davies, Frederik Persson
Sotagliflozin, a dual sodium-glucose co-transporter-1 and sodium-glucose co-transporter-2 inhibitor, reduces the risk of cardiovascular and kidney disease, as assessed by the Steno T1 Risk Engine in adults with type 1 diabetes. Diabetes, obesity & metabolism (2023)
Sankar D Navaneethan, Sophia Zoungas, M Luiza Caramori, Juliana Chung Ngor Chan, Hiddo J Lambers Heerspink, Clint Hurst, Adrian Liew, Erin Donelly Michos, Wasiu A Olowu, Tami Sadusky, Nikhil Tandon, Katherine R Tuttle, Christoph Wanner, Katy G Wilkens, Jonathan C Craig, David J Tunnicliffe, Marcello Tonelli, Michael Cheung, Amy Earley, Ellen Burgess, Ian H de Boer, Kamlesh Khunti
Diabetes Management in Chronic Kidney Disease: Synopsis of the KDIGO 2022 Clinical Practice Guideline Update. Annals of internal medicine 176 (3) (2023)
Glenn M Chertow, Ricardo Correa-Rotter, Priya Vart, Niels Jongs, John Joseph Valentine McMurray, Ellen Burgess, Anna Maria Langkilde, C David Sjöström, Robert D Toto, David C Wheeler, Hiddo J Lambers Heerspink, null null
Effects of Dapagliflozin in Chronic Kidney Disease, With and Without Other Cardiovascular Medications: DAPA-CKD Trial. Journal of the American Heart Association (2023)
Rajiv Agarwal, Wanzhu F Tu, Alfredo E Farjat, Youssef M K Farag, Robert D Toto, Sanjay Kaul, Robert Lawatscheck, Katja Rohwedder, Luis M Ruilope, Ellen Burgess, Bertram Pitt, Gerasimos S Filippatos, Stefan D Anker, George L Bakris, null null
Impact of Finerenone-Induced Albuminuria Reduction on Chronic Kidney Disease Outcomes in Type 2 Diabetes : A Mediation Analysis. Annals of internal medicine (2023)
Priya Vart, Jawad H Butt, Niels Jongs, Meir Schechter, Glenn M Chertow, David C Wheeler, Roberto Flavio Pecoits-Filho, Anna Maria Langkilde, Ricardo Correa-Rotter, Ellen Burgess, John J V McMurray, Hiddo J L Heerspink
Efficacy and Safety of Dapagliflozin in Patients with Chronic Kidney Disease across the Spectrum of Frailty. The journals of gerontology. Series A, Biological sciences and medical sciences (2023)
Roderick C Slieker, Louise A Donnelly, Elina Akalestou, Livia Lopez-Noriega, Rana Melhem, Ayşim Güneş, Frederic Abou Azar, Alexander Efanov, Eleni Georgiadou, Hermine Muniangi-Muhitu, Mahsa Sheikh, Giuseppe N Giordano, Mikael Åkerlund, Emma Ahlqvist, Ashfaq Ali, Karina Banasik, Soren Brunak, Marko Barovic, Gerard A Bouland, Frédéric Burdet, Mickaël Canouil, Iulian Dragan, Petra J M Elders, Céline Fernandez, Andreas Festa, Hugo Fitipaldi, Phillippe Froguel, Valborg Gudmundsdottir, Vilmundur G Gudnason, Mathias J Gerl, Amber A van der Heijden, Lori L Jennings, Michael K Hansen, Min Kim, Isabelle Leclerc, Christian Klose, Dmitry Kuznetsov, Dina Mansour Aly, Florence Mehl, Diana Marek, Olle Melander, Anne Niknejad, Filip Ottosson, Imre Pavo, Kevin Duffin, Samreen K Syed, Janice L Shaw, Over Cabrera, Timothy J Pullen, Kai Simons, Michele Solimena, Tommi Suvitaival, Asger Wretlind, Ellen Burgess, Valeriya Lyssenko, Cristina Legido Quigley, Leif C Groop, Bernard Thorens, Paul W Franks, Gareth E Lim, Jennifer L Estall, Mark Ibberson, Joline Wilhelma Johanna Beulens, Leen M 't Hart, Ewan R Pearson, Guy A Rutter
Identification of biomarkers for glycaemic deterioration in type 2 diabetes. Nature communications 14 (1) (2023)
Glenn M Chertow, Ricardo Correa-Rotter, Priya Vart, Niels Jongs, John Joseph Valentine McMurray, Ellen Burgess, Anna Maria Langkilde, C David Sjöström, Robert D Toto, David C Wheeler, Hiddo J Lambers Heerspink, null null
Effects of Dapagliflozin in Chronic Kidney Disease, With and Without Other Cardiovascular Medications: DAPA-CKD Trial. Journal of the American Heart Association 12 (9) (2023)
Roderick C Slieker, Louise A Donnelly, Elina Akalestou, Livia Lopez-Noriega, Rana Melhem, Ayşim Güneş, Frederic Abou Azar, Alexander Efanov, Eleni Georgiadou, Hermine Muniangi-Muhitu, Mahsa Sheikh, Giuseppe N Giordano, Mikael Åkerlund, Emma Ahlqvist, Ashfaq Ali, Karina Banasik, Soren Brunak, Marko Barovic, Gerard A Bouland, Frédéric Burdet, Mickaël Canouil, Iulian Dragan, Petra J M Elders, Céline Fernandez, Andreas Festa, Hugo Fitipaldi, Phillippe Froguel, Valborg Gudmundsdottir, Vilmundur G Gudnason, Mathias J Gerl, Amber A van der Heijden, Lori L Jennings, Michael K Hansen, Min Kim, Isabelle Leclerc, Christian Klose, Dmitry Kuznetsov, Dina Mansour Aly, Florence Mehl, Diana Marek, Olle Melander, Anne Niknejad, Filip Ottosson, Imre Pavo, Kevin Duffin, Samreen K Syed, Janice L Shaw, Over Cabrera, Timothy J Pullen, Kai Simons, Michele Solimena, Tommi Suvitaival, Asger Wretlind, Ellen Burgess, Valeriya Lyssenko, Cristina Legido Quigley, Leif C Groop, Bernard Thorens, Paul W Franks, Gareth E Lim, Jennifer L Estall, Mark Ibberson, Joline Wilhelma Johanna Beulens, Leen M 't Hart, Ewan R Pearson, Guy A Rutter
Identification of biomarkers for glycaemic deterioration in type 2 diabetes. Nature communications 14 (1) (2023)
Janet B McGill, Rajiv Agarwal, Stefan D Anker, George L Bakris, Gerasimos Filippatos, Bertram Pitt, Luis M Ruilope, Andreas L Birkenfeld, Maria L Caramori, Meike Brinker, Amer Joseph, Andrea Lage, Robert Lawatscheck, Charlie Scott, Ellen Burgess, null null
Effects of finerenone in people with chronic kidney disease and type 2 diabetes are independent of HbA1c at baseline, HbA1c variability, diabetes duration and insulin use at baseline. Diabetes, obesity & metabolism (2023)
Glenn M Chertow, Ricardo Correa-Rotter, Priya Vart, Niels Jongs, John Joseph Valentine McMurray, Ellen Burgess, Anna Maria Langkilde, C David Sjöström, Robert D Toto, David C Wheeler, Hiddo J Lambers Heerspink, null null
Effects of Dapagliflozin in Chronic Kidney Disease, With and Without Other Cardiovascular Medications: DAPA-CKD Trial. Journal of the American Heart Association 12 (9) (2023)
Hashmat Sayed Zohori Bahrami, Peter Godsk Jørgensen, Jens Dahlgaard Hove, Ulrik Dixen, Tor Biering-Sørensen, Ellen Burgess, Magnus T Jensen
Prognostic value of myocardial performance index in individuals with type 1 and type 2 diabetes: Thousand&1 and Thousand&2 studies. European heart journal. Cardiovascular Imaging (2023)
Ellen Burgess, Florian M M Baeres, George Bakris, Heidrun Bosch-Traberg, Mette Gislum, Stephen C L Gough, Thomas Idorn, Jack Lawson, Kenneth W Mahaffey, Johannes F E Mann, Henriette Mersebach, Vlado Perkovic, Katherine Tuttle, Richard Pratley
The rationale, design and baseline data of FLOW, a kidney outcomes trial with once-weekly semaglutide in people with type 2 diabetes and chronic kidney disease. Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association (2023)
Lesley A Inker, Hocine Tighiouart, Ogechi M Adingwupu, Michael G Shlipak, Alessandro Doria, Michelle M Estrella, Marc Froissart, Vilmundur G Gudnason, Gabriel Grubb, Roberto Kalil, Michael Mauer, Ellen Burgess, Jesse Seegmiller, Josef Coresh, Andrew S Levey
CKD-EPI and EKFC GFR Estimating Equations: Performance and Other Considerations for Selecting Equations for Implementation in Adults. Journal of the American Society of Nephrology : JASN (2023)
Gerasimos S Filippatos, Stefan D Anker, Phyllis August, Andrew J S Coats, James L Januzzi, Boris Mankovsky, Ellen Burgess, Luis M Ruilope, Bertram Pitt, Pantelis A Sarafidis, John R Teerlink, Chris J Kapelios, Martin Gebel, Meike Brinker, Amer Joseph, Andrea Lage, George Bakris, Rajiv Agarwal, null null
Finerenone and effects on mortality in chronic kidney disease and type 2 diabetes: a FIDELITY analysis. European heart journal. Cardiovascular pharmacotherapy (2023)
Janet B McGill, Rajiv Agarwal, Stefan D Anker, George L Bakris, Gerasimos Filippatos, Bertram Pitt, Luis M Ruilope, Andreas L Birkenfeld, M Luiza Caramori, Meike Brinker, Amer Joseph, Andrea Lage, Robert Lawatscheck, Charlie Scott, Ellen Burgess, null null
Effects of finerenone in persons with CKD and T2D are independent of HbA1c at baseline, HbA1c variability, diabetes duration and insulin use at baseline. Diabetes, obesity & metabolism (2023)
Sankar D Navaneethan, Sophia Zoungas, M Luiza Caramori, Juliana Chung Ngor Chan, Hiddo J Lambers Heerspink, Clint Hurst, Adrian Liew, Erin Donelly Michos, Wasiu A Olowu, Tami Sadusky, Nikhil Tandon, Katherine R Tuttle, Christoph Wanner, Katy G Wilkens, Jonathan C Craig, David J Tunnicliffe, Marcello Tonelli, Michael Cheung, Amy Earley, Ellen Burgess, Ian H de Boer, Kamlesh Khunti
Diabetes Management in Chronic Kidney Disease: Synopsis of the KDIGO 2022 Clinical Practice Guideline Update. Annals of internal medicine (2023)
Elisabeth Buur Stougaard, Ellen Burgess, Dorte Vistisen, Phillip Banks, Manon Girard, Michael J Davies, Frederik Persson
Sotagliflozin, a dual SGLT1 and SGLT2 inhibitor, reduces the risk of cardiovascular and kidney disease as assessed by Steno T1 Risk Engine in adults with type 1 diabetes. Diabetes, obesity & metabolism (2023)
Elisabeth Buur Stougaard, Hanan Amadid, Esben Søndergaard, Bendix Carstensen, Marit Eika Jorgensen, Kirsten Nørgaard, Ellen Burgess, Stephen C Bain, Dorte Vistisen
Time Trends in the Incidence of Diabetic Ketoacidosis Leading to Hospital Admission Among Adults With Type 1 Diabetes-A Nationwide Danish Register Study. Diabetes care (2023)
Sankar D Navaneethan, Sophia Zoungas, M Luiza Caramori, Juliana Chung Ngor Chan, Hiddo J Lambers Heerspink, Clint Hurst, Adrian Liew, Erin Donelly Michos, Wasiu A Olowu, Tami Sadusky, Nikhil Tandon, Katherine R Tuttle, Christoph Wanner, Katy G Wilkens, Jonathan C Craig, David J Tunnicliffe, Marcello Tonelli, Michael Cheung, Amy Earley, Ellen Burgess, Ian H de Boer, Kamlesh Khunti
Diabetes Management in Chronic Kidney Disease: Synopsis of the KDIGO 2022 Clinical Practice Guideline Update. Annals of internal medicine 176 (3) (2023)
Gerasimos S Filippatos, Stefan D Anker, Phyllis August, Andrew J S Coats, James L Januzzi, Boris Mankovsky, Ellen Burgess, Luis M Ruilope, Bertram Pitt, Pantelis A Sarafidis, John R Teerlink, Chris J Kapelios, Martin Gebel, Meike Brinker, Amer Joseph, Andrea Lage, George Bakris, Rajiv Agarwal
Finerenone and effects on mortality in chronic kidney disease and type 2 diabetes: a FIDELITY analysis. European heart journal. Cardiovascular pharmacotherapy 9 (2) (2023)
Robert A Fletcher, Niels Jongs, Glenn M Chertow, John Joseph Valentine McMurray, Clare Arnott, Meg J Jardine, Kenneth W Mahaffey, Vlado Perkovic, Patrick Rockenschaub, Ellen Burgess, Ricardo Correa-Rotter, Robert D Toto, Muthiah Vaduganathan, David C Wheeler, Hiddo J Lambers Heerspink, Brendon L Neuen
Effect of SGLT2 Inhibitors on Discontinuation of Renin-angiotensin System Blockade: A Joint Analysis of the CREDENCE and DAPA-CKD Trials. Journal of the American Society of Nephrology : JASN (2023)
Hatice Isik Mizrak, Tine Willum Hansen, Ellen Burgess, Viktor Rotbain Curovic, Dorte Vistisen, Hanan Amadid, Christian Stevns Hansen
Declining Incidence Rates of Distal Symmetric Polyneuropathy in People With Type 1 and Type 2 Diabetes in Denmark, With Indications of Distinct Patterns in Type 1 Diabetes. Diabetes care (2023)
Glenn M Chertow, Ricardo Correa-Rotter, Priya Vart, Niels Jongs, John Joseph Valentine McMurray, Ellen Burgess, Anna Maria Langkilde, C David Sjöström, Robert D Toto, David C Wheeler, Hiddo J Lambers Heerspink, null null
Effects of Dapagliflozin in Chronic Kidney Disease, With and Without Other Cardiovascular Medications: DAPA-CKD Trial. Journal of the American Heart Association 12 (9) (2023)
Glenn M Chertow, Ricardo Correa-Rotter, Priya Vart, Niels Jongs, John Joseph Valentine McMurray, Ellen Burgess, Anna Maria Langkilde, C David Sjöström, Robert D Toto, David C Wheeler, Hiddo J Lambers Heerspink, null null
Effects of Dapagliflozin in Chronic Kidney Disease, With and Without Other Cardiovascular Medications: DAPA-CKD Trial. Journal of the American Heart Association 12 (9) (2023)
Mikkel Jürgens, Morten Schou, Philip Hasbak, Andreas Kjaer, Emil Wolsk, Bo Zerahn, Niels Høegh Brandt-Jacobsen, Peter Haulund Gaede, Ellen Burgess, Jens Faber, Silvio E Inzucchi, Finn Gustafsson, Caroline Kistorp
The effects of empagliflozin on measured glomerular filtration rate and estimated extracellular and plasma volumes in patients with type 2 diabetes. Diabetes, obesity & metabolism (2023)
Viktor Rotbain Curovic, Morten B Houlind, Marjolein Y A M Kroonen, Niels Jongs, Emilie H Zobel, Tine Willum Hansen, Juliette Tavenier, Jesper Eugen-Olsen, Gozewijn D Laverman, Adriaan Kooy, Frederik Persson, Ellen Burgess, Hiddo J Lambers Heerspink
Overall and inter-individual effect of four different drug classes on soluble urokinase plasminogen activator receptor in type 1 and type 2 diabetes. Diabetes, obesity & metabolism (2023)
Ellen Burgess, Stefan D Anker, Gerasimos Filippatos, Bertram Pitt, Luis M Ruilope, Liana K Billings, Jennifer B Green, Daisuke Koya, Lawrence A Leiter, Kevin M Pantalone, Christiane Ahlers, Andrea Lage, Robert Lawatscheck, Andrea Scalise, George L Bakris
The impact of obesity on cardiovascular and kidney outcomes in patients with chronic kidney disease and type 2 diabetes treated with finerenone: Post hoc analysis of the FIDELITY study. Diabetes, obesity & metabolism (2023)
Christina Gjerlev Poulsen, Daniel G K Rasmussen, Federica Genovese, Tine W Hansen, Signe Holm Nielsen, Henrik Reinhard, Bernt Johan von Scholten, Peter K Jacobsen, Hans-Henrik Parving, Morten Asser Karsdal, Ellen Burgess, Marie Frimodt-Møller
Marker for kidney fibrosis is associated with inflammation and deterioration of kidney function in people with type 2 diabetes and microalbuminuria. PloS one 18 (3) (2023)
Roderick C Slieker, Louise A Donnelly, Elina Akalestou, Livia Lopez-Noriega, Rana Melhem, Ayşim Güneş, Frederic Abou Azar, Alexander Efanov, Eleni Georgiadou, Hermine Muniangi-Muhitu, Mahsa Sheikh, Giuseppe N Giordano, Mikael Åkerlund, Emma Ahlqvist, Ashfaq Ali, Karina Banasik, Soren Brunak, Marko Barovic, Gerard A Bouland, Frédéric Burdet, Mickaël Canouil, Iulian Dragan, Petra J M Elders, Céline Fernandez, Andreas Festa, Hugo Fitipaldi, Phillippe Froguel, Valborg Gudmundsdottir, Vilmundur G Gudnason, Mathias J Gerl, Amber A van der Heijden, Lori L Jennings, Michael K Hansen, Min Kim, Isabelle Leclerc, Christian Klose, Dmitry Kuznetsov, Dina Mansour Aly, Florence Mehl, Diana Marek, Olle Melander, Anne Niknejad, Filip Ottosson, Imre Pavo, Kevin Duffin, Samreen K Syed, Janice L Shaw, Over Cabrera, Timothy J Pullen, Kai Simons, Michele Solimena, Tommi Suvitaival, Asger Wretlind, Ellen Burgess, Valeriya Lyssenko, Cristina Legido Quigley, Leif C Groop, Bernard Thorens, Paul W Franks, Gareth E Lim, Jennifer L Estall, Mark Ibberson, Joline Wilhelma Johanna Beulens, Leen M 't Hart, Ewan R Pearson, Guy A Rutter
Identification of biomarkers for glycaemic deterioration in type 2 diabetes. Nature communications 14 (1) (2023)
Sankar D Navaneethan, Sophia Zoungas, M Luiza Caramori, Juliana Chung Ngor Chan, Hiddo J Lambers Heerspink, Clint Hurst, Adrian Liew, Erin Donelly Michos, Wasiu A Olowu, Tami Sadusky, Nikhil Tandon, Katherine R Tuttle, Christoph Wanner, Katy G Wilkens, Jonathan C Craig, David J Tunnicliffe, Marcello Tonelli, Michael Cheung, Amy Earley, Ellen Burgess, Ian H de Boer, Kamlesh Khunti
Diabetes Management in Chronic Kidney Disease: Synopsis of the KDIGO 2022 Clinical Practice Guideline Update. Annals of internal medicine 176 (3) (2023)
Christina Gjerlev Poulsen, Daniel G K Rasmussen, Federica Genovese, Tine W Hansen, Signe Holm Nielsen, Henrik Reinhard, Bernt Johan von Scholten, Peter K Jacobsen, Hans-Henrik Parving, Morten Asser Karsdal, Ellen Burgess, Marie Frimodt-Møller
Marker for kidney fibrosis is associated with inflammation and deterioration of kidney function in people with type 2 diabetes and microalbuminuria. PloS one 18 (3) (2023)
Karina Haar Jensen, Stephen C Bain, Ditte Hansen, Iain Bressendorff, Marie Møller, Ellen Burgess, Eva Gravesen, Vanja Kosjerina, Dorte Vistisen, Rikke Borg
Design and methodology of the PRIMETIME 1 cohort study: PRecIsion MEdicine based on kidney TIssue Molecular interrogation in diabetic nEphropathy. Clinical kidney journal 16 (12) (2023)
Rajiv Agarwal, Bertram Pitt, Biff F Palmer, Csaba Pal Kovesdy, Ellen Burgess, Gerasimos Filippatos, Jolanta Małyszko, Luis M Ruilope, Patrick Rossignol, Ellen Burgess, Roberto Pecoits-Filho, Stefan D Anker, Amer Joseph, Robert Lawatscheck, Daniel Wilson, Martin Gebel, George L Bakris
A comparative post hoc analysis of finerenone and spironolactone in resistant hypertension in moderate-to-advanced chronic kidney disease. Clinical kidney journal 16 (2) (2022)
Ninna Hahn Tougaard, Alexandra Louise Møller, Pernille Falberg Rønn, Tine Willum Hansen, Federica Genovese, Morten Asser Karsdal, Daniel Guldager Kring Rasmussen, Ellen Burgess
Endotrophin as a Marker of Complications in a Type 2 Diabetes Cohort. Diabetes care 45 (11) (2022)
Thomas W Winkler, Humaira Rasheed, Alexander Teumer, Mathias Gorski, Bryce X Rowan, Kira J Stanzick, Laurent F Thomas, Adrienne Tin, Anselm Hoppmann, Audrey Y Chu, Bamidele Tayo, Chris H L Thio, Daniele Cusi, Jin-Fang Chai, Karsten B Sieber, Katrin Horn, Man Li, Markus Scholz, Massimiliano Cocca, Matthias Wuttke, Peter J van der Most, Qiong Yang, Sahar Ghasemi, Teresa Nutile, Yong Li, Giulia Pontali, Felix Günther, Abbas Dehghan, Adolfo Correa, Afshin Parsa, Agnese Feresin, Aiko P J de Vries, Alan B Zonderman, Albert Vernon Smith, Albertine J Oldehinkel, Alessandro De Grandi, Alexander R Rosenkranz, Andre Franke, Andrej Teren, Andres Metspalu, Andrew A Hicks, Andrew P Morris, Anke Tönjes, Anna Morgan, Anna I Podgornaia, Annette Peters, Antje Körner, Anubha Mahajan, Archie Campbell, Barry I Freedman, Beatrice Spedicati, Belen Ponte, Ben Schöttker, Ben Michael Brumpton, Bernhard Banas, Bernhard K Krämer, Bettina Jung, Bjørn Olav Åsvold, Blair H Smith, Boting Ning, Brenda W J H Penninx, Brett R Vanderwerff, Bruce M Psaty, Candace M Kammerer, Carl D Langefeld, Caroline Hayward, Cassandra N Spracklen, Cassianne Robinson-Cohen, Catharina A Hartman, Cecilia M Lindgren, Chaolong Wang, Sabanayagam Charumathi, Chew-Kiat Heng, Chiara Lanzani, Chiea Chuen Khor, Ching-Yu Cheng, Christian Fuchsberger, Christian Gieger, Christian M Shaffer, Christina-Alexandra Schulz, Cristen J Willer, Daniel I Chasman, Daniel F Gudbjartsson, Daniela Ruggiero, Daniela Toniolo, Darina Czamara, David J Porteous, Dawn M Waterworth, Deborah Mascalzoni, Dennis O Mook-Kanamori, Dermot F Reilly, E Warwick Daw, Edith Hofer, Eric Boerwinkle, Erika Salvi, Erwin P Bottinger, E-Shyong Tai, Eulalia Catamo, Federica Rizzi, Feng Guo, Fernando Rivadeneira, Franco Guilianini, Gardar Sveinbjornsson, Georg Ehret, Gerard Waeber, Ginevra Biino, Giorgia Girotto, Giorgio Pistis, Girish N Nadkarni, Graciela E Delgado, Grant W Montgomery, Harold Snieder, Harry Campbell, Harvey D White, He Gao, Heather M Stringham, Helena Schmidt, Hengtong Li, Hermann Brenner, Hilma Hólm, Holgen Kirsten, Holly Kramer, Igor Rudan, Ilja M Nolte, Ioanna Tzoulaki, Isleifur Olafsson, Jade Martins, James P Cook, James F Wilson, Jan Halbritter, Janine F Felix, Jasmin Divers, Jaspal S Kooner, Jeannette Jen-Mai Lee, Jeffrey O'Connell, Jerome I Rotter, Jian-Jun Liu, Jie Xu, Joachim Thiery, Johan Ärnlöv, Johanna Kuusisto, Johanna Jakobsdottir, Johanne Tremblay, John C Chambers, John B Whitfield, John M Gaziano, Jonathan Marten, Josef Coresh, Jost Bruno Jonas, Josyf C Mychaleckyi, Kaare Christensen, Kai-Uwe Eckardt, Karen L Mohlke, Karlhans Endlich, Katalin Dittrich, Kathleen A Ryan, Kenneth M Rice, Kent D Taylor, Kevin Ho, Kjell Nikus, Koichi Matsuda, Konstantin Strauch, Kozeta Miliku, Kristian Hveem, Lars Lind, Lars Wallentin, Laura M Yerges-Armstrong, Laura M Raffield, Lawrence S Phillips, Lenore J Launer, Leo-Pekka Lyytikäinen, Leslie A Lange, Lorena Citterio, Lucija Klaric, Mohammad Arfan Ikram, Marcus Ising, Marcus E Kleber, Margherita Francescatto, Maria Pina Concas, Marina Ciullo, Mario Piratsu, Marju Orho-Melander, Markku Laakso, Markus Loeffler, Markus Perola, Martin H de Borst, Martin Gögele, Martina La Bianca, Mary Ann Lukas, Mary F Feitosa, Mary L Biggs, Mary K Wojczynski, Maryam Kavousi, Masahiro Kanai, Masato Akiyama, Masayuki Yasuda, Matthias Nauck, Melanie Waldenberger, Miao-Li Chee, Miao-Ling Chee, Michael Boehnke, Michael H Preuss, Michael Stumvoll, Michael A Province, Michele K Evans, Michelle L O'Donoghue, Michiaki Kubo, Mika Kähönen, Mika Kastarinen, Mike A Nalls, Mikko Kuokkanen, Mohsen Ghanbari, Murielle Bochud, Navya Shilpa Josyula, Nicholas G Martin, Nicholas Y Q Tan, Nicholette D Palmer, Nicola Pirastu, Nicole Schupf, Niek Verweij, Nina Hutri-Kähönen, Nina Mononen, Nisha Bansal, Olivier Devuyst, Olle Melander, Olli T Raitakari, Ozren Polasek, Paolo Manunta, Paolo Gasparini, Pashupati P Mishra, Patrick Sulem, Patrik K E Magnusson, Paul Elliott, Paul M Ridker, Pavel Hamet, Per O Svensson, Peter K Joshi, Peter Kovacs, Peter P Pramstaller, Ellen Burgess, Peter Vollenweider, Pim van der Harst, Rajkumar Dorajoo, Ralene Z H Sim, Ralph Burkhardt, Ran Tao, Raymond Noordam, Reedik Mägi, Reinhold Schmidt, Renée de Mutsert, Rico Rueedi, Rob M van Dam, Robert J Carroll, Ron T Gansevoort, Ruth J F Loos, Sala Cinzia Felicita, Sanaz Sedaghat, Sandosh Padmanabhan, Sandra Freitag-Wolf, Sarah A Pendergrass, Sarah E Graham, Scott D Gordon, Shih-Jen Hwang, Shona M Kerr, Simona Vaccargiu, Snehal B Patil, Stein Hallan, Stephan J L Bakker, Su-Chi Lim, Susanne Lucae, Suzanne Vogelezang, Sven Bergmann, Tanguy Corre, Tarunveer Singh Ahluwalia, Terho Lehtimäki, Thibaud S Boutin, Thomas Meitinger, Tien-Yin Wong, Tobias Bergler, Ton J Rabelink, Tõnu Esko, Toomas Haller, Unnur Thorsteinsdottir, Uwe Völker, Valencia Hui Xian Foo, Veikko V Salomaa, Veronique Vitart, Vilmantas Giedraitis, Vilmundur G Gudnason, Vincent W V Jaddoe, Wei Huang, Weihua Zhang, Wen Bin Wei, Wieland Kiess, Winfried März, Wolfgang Koenig, Wolfgang Lieb, Xin Gao, Xueling S Sim, Ya-Xing Wang, Yechiel Friedlander, Yih-Chung Tham, Yoichiro Kamatani, Yukinori Okada, Yuri Milaneschi, Zhi Yu, null null, null null, null null, Klaus J Stark, Kári Stefánsson, Carsten A Böger, Adriana M Hung, Florian Kronenberg, Anna Köttgen, Cristian Pattaro, Iris M Heid
Differential and shared genetic effects on kidney function between diabetic and non-diabetic individuals. Communications biology 5 (1) (2022)
Ellen Burgess, Justus G Garweg, Stefan D Anker, Takeshi Osonoi, Bertram Pitt, Sylvia E Rosas, Luis Miguel Ruilope, Da-Long Zhu, Meike Brinker, David Finis, Sergio Leal, Thomas Schmelter, George Bakris
Effect of finerenone on the occurrence of vision-threatening complications in patients with non-proliferative diabetic retinopathy: Pooled analysis of two studies using routine ophthalmological examinations from clinical trial participants (ReFineDR/DeFineDR). Diabetes, obesity & metabolism (2022)
Luis M Ruilope, Bertram Pitt, Stefan D Anker, Ellen Burgess, Csaba Pal Kovesdy, Roberto Pecoits-Filho, Pablo Pergola, Amer Joseph, Andrea Lage, Nicole Mentenich, Markus F Scheerer, George L Bakris
Kidney outcomes with finerenone: An analysis from the FIGARO-DKD study. Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association (2022)
Melanie Jane Davies, Vanita R Aroda, Billy S Collins, Robert A Gabbay, Jennifer Green, Nisa M Maruthur, Sylvia E Rosas, Stephano Del Prato, Chantal Mathieu, Geltrude Mingrone, Ellen Burgess, Tsvetalina Tankova, Apostolos Tsapas, John B Buse
Management of Hyperglycemia in Type 2 Diabetes, 2022. A Consensus Report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD). Diabetes care 45 (11) (2022)
Peter Rossing, Ellen Burgess, Rajiv Agarwal, Stefan D Anker, Gerasimos Filippatos, Bertram Pitt, Luis M Ruilope, Pieter Gillard, Richard J MacIsaac, Julio Wainstein, Amer Joseph, Meike Brinker, Lothar Roessig, Charlie Scott, George L Bakris, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null
Finerenone in Patients With Chronic Kidney Disease and Type 2 Diabetes According to Baseline HbA1c and Insulin Use: An Analysis From the FIDELIO-DKD Study. Diabetes care 45 (4) (2022)
Niels H Brandt-Jacobsen, Mikkel Jürgens, Philip Hasbak, Peter Gaede, Ellen Burgess, Jon J Rasmussen, Camillla Fuchs Andersen, Julie L Forman, Jens Faber, Catherine M Viscoli, Finn Gustafsson, Morten Schou, Caroline Kistorp
Reduction of cardiac adipose tissue volume with short-term empagliflozin treatment in patients with type 2 diabetes: a sub-study from the SIMPLE randomized clinical trial. Diabetes, obesity & metabolism (2022)
Melanie Jane Davies, Vanita R Aroda, Billy S Collins, Robert A Gabbay, Jennifer Green, Nisa M Maruthur, Sylvia E Rosas, Stephano Del Prato, Chantal Mathieu, Geltrude Mingrone, Ellen Burgess, Tsvetalina Tankova, Apostolos Tsapas, John B Buse
Management of hyperglycaemia in type 2 diabetes, 2022. A consensus report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD). Diabetologia 65 (12) (2022)
Niels Jongs, Glenn M Chertow, Tom Greene, John J V McMurray, Anna Maria Langkilde, Ricardo Correa-Rotter, Naoki Kashihara, Ellen Burgess, C David Sjöström, Bergur V Stefánsson, Robert D Toto, David C Wheeler, Hiddo J Lambers Heerspink, null null, null null
Correlates and Consequences of an Acute Change in eGFR in Response to the SGLT2 Inhibitor Dapagliflozin in Patients with CKD. Journal of the American Society of Nephrology : JASN 33 (11) (2022)
Ellen Burgess, Michael Gwilt
Preconception Antidiabetic Drugs in Men and Birth Defects in Offspring. Annals of internal medicine 175 (9) (2022)
Hiddo J Lambers Heerspink, Glenn M Chertow, Niels Jongs, Ricardo Correa-Rotter, Ellen Burgess, C David Sjöström, Anna Maria Langkilde, David C Wheeler, null null
Effects of Dapagliflozin in People without Diabetes and with Microalbuminuria. Clinical journal of the American Society of Nephrology : CJASN 17 (11) (2022)
Jens Christian Laursen, Niels Søndergaard Heinrich, Bryan Haddock, Ida Kirstine Bull Rasmussen, Christian Stevns Hansen, Henrik Bo Wiberg Larsson, Per-Henrik Groop, Petter Bjornstad, Marie Frimodt-Møller, Ulrik Bjørn Andersen, Ellen Burgess
Kidney oxygenation, perfusion and blood flow in people with and without type 1 diabetes. Clinical kidney journal 15 (11) (2022)
Phil McEwan, Rebecca Boyce, Juan Jose Garcia Sanchez, C David Sjöström, Bergur Stefansson, Stephen Nolan, Ricardo Correa-Rotter, Ellen Burgess, Glenn M Chertow, John J V McMurray, David C Wheeler, Hiddo J Lambers Heerspink
Extrapolated longer-term effects of the DAPA-CKD trial: a modelling analysis. Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association (2022)
Ellen Burgess, Rajiv Agarwal, Stefan D Anker, Gerasimos Filippatos, Bertram Pitt, Luis M Ruilope, Vivian A Fonseca, Guillermo E Umpierrez, Maria Luiza Caramori, Amer Joseph, Marc Lambelet, Robert Lawatscheck, George L Bakris, null null
Finerenone in patients across the spectrum of chronic kidney disease and type 2 diabetes by glucagon-like peptide-1 receptor agonist use. Diabetes, obesity & metabolism (2022)
Rong M Zhang, Stephen C Bain, Janet B McGill, Ellen Burgess
Clinical implications and guidelines for CKD in type 2 diabetes. Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association (2022)
Meir Schechter, Niels Jongs, Glenn M Chertow, Lawrence A Leiter, John Joseph Valentine McMurray, Ricardo Correa-Rotter, Ellen Burgess, Anna Maria Langkilde, C David Sjöström, Robert D Toto, David C Wheeler, Hiddo J Lambers Heerspink
Effects of Dapagliflozin on Hospitalizations in Patients With Chronic Kidney Disease : A Post Hoc Analysis of DAPA-CKD. Annals of internal medicine (2022)
Janet B McGill, Hermann Haller, Prabir Roy-Chaudhury, Andrea Cherrington, Takashi Wada, Christoph Wanner, Linong Ji, Ellen Burgess
Making an impact on kidney disease in people with type 2 diabetes: the importance of screening for albuminuria. BMJ open diabetes research & care 10 (4) (2022)
Ellen Burgess, Stefan D Anker, Gerasimos Filippatos, Bertram Pitt, Luis M Ruilope, Andreas L Birkenfeld, Janet B McGill, Sylvia E Rosas, Amer Joseph, Martin Gebel, Luke Roberts, Markus F Scheerer, George L Bakris, Rajiv Agarwal
Finerenone in Patients With Chronic Kidney Disease and Type 2 Diabetes by Sodium-Glucose Cotransporter 2 Inhibitor Treatment: The FIDELITY Analysis. Diabetes care (2022)
Jonas Askø Andersen, Anne Rasmussen, Susanne Engberg, Jesper Bencke, Marie Frimodt-Møller, Klaus Kirketerp-Møller, Ellen Burgess
Flexor Tendon Tenotomy Treatment of the Diabetic Foot: A Multicenter Randomized Controlled Trial. Diabetes care 45 (11) (2022)
Jens Christian Laursen, Niels Søndergaard Heinrich, Bryan Haddock, Ida Kirstine Bull Rasmussen, Christian Stevns Hansen, Henrik Bo Wiberg Larsson, Per-Henrik Groop, Petter Bjornstad, Marie Frimodt-Møller, Ulrik Bjørn Andersen, Ellen Burgess
Kidney oxygenation, perfusion and blood flow in people with and without type 1 diabetes. Clinical kidney journal 15 (11) (2022)
Ellen Burgess, Jorma Strand, Angelo Avogaro, Michael Becka, Friederike Kanefendt, Christiane Otto
Effects of the chymase inhibitor fulacimstat in diabetic kidney disease-results from the CADA DIA trial. Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 36 (12) (2022)
Rajiv Agarwal, Gerasimos Filippatos, Bertram Pitt, Stefan D Anker, Ellen Burgess, Amer Joseph, Peter Kolkhof, Christina Nowack, Martin Gebel, Luis M Ruilope, George L Bakris, null null
Cardiovascular and kidney outcomes with finerenone in patients with type 2 diabetes and chronic kidney disease: the FIDELITY pooled analysis. European heart journal 43 (6) (2022)
Rajiv Agarwal, Bertram Pitt, Biff F Palmer, Csaba Pal Kovesdy, Ellen Burgess, Gerasimos Filippatos, Jolanta Małyszko, Luis M Ruilope, Patrick Rossignol, Ellen Burgess, Roberto Pecoits-Filho, Stefan D Anker, Amer Joseph, Robert Lawatscheck, Daniel Wilson, Martin Gebel, George L Bakris
A comparative post hoc analysis of finerenone and spironolactone in resistant hypertension in moderate-to-advanced chronic kidney disease. Clinical kidney journal 16 (2) (2022)
Jens Christian Laursen, Hatice Isik Mizrak, Huda Kufaishi, Sofie Korsgaard Hecquet, Elisabeth Buur Stougaard, Ninna Hahn Tougaard, Marie Frimodt-Møller, Tine Willum Hansen, Christian Stevns Hansen, Ellen Burgess
Lower blood oxygen saturation is associated with microvascular complications in individuals with type 1 diabetes. The Journal of clinical endocrinology and metabolism (2022)
Christine P Limonte, Erkka Valo, Viktor Drel, Loki Natarajan, Manjula Darshi, Carol Forsblom, Clark M Henderson, Andrew N Hoofnagle, Wenjun Ju, Matthias Kretzler, Daniel Montemayor, Viji Nair, Robert G Nelson, John F O'Toole, Robert D Toto, Sylvia E Rosas, John Ruzinski, Erkka Valo, Insa M Schmidt, Tomas Vaisar, Sushrut S Waikar, Jing Zhang, Ellen Burgess, Tarunveer S Ahluwalia, Per-Henrik Groop, Subramaniam Pennathur, Janet K Snell-Bergeon, Tina Costacou, Trevor J Orchard, Kumar Sharma, Ian H de Boer, null null
Urinary Proteomics Identifies Cathepsin D as a Biomarker of Rapid eGFR Decline in Type 1 Diabetes. Diabetes care 45 (6) (2022)
Luis M Ruilope, Rajiv Agarwal, Stefan D Anker, Gerasimos S Filippatos, Bertram Pitt, Ellen Burgess, Pantelis A Sarafidis, Roland Erich Schmieder, Amer Joseph, Nicole Mentenich, Christina Nowack, George L Bakris, null null
Blood Pressure and Cardiorenal Outcomes With Finerenone in Chronic Kidney Disease in Type 2 Diabetes. Hypertension (Dallas, Tex. : 1979) 79 (12) (2022)
Simke W Waijer, Priya Vart, David Z I Cherney, Glenn M Chertow, Niels Jongs, Anna Maria Langkilde, Johannes F E Mann, Ofri Mosenzon, John Joseph Valentine McMurray, Ellen Burgess, Ricardo Correa-Rotter, Bergur V Stefansson, Robert D Toto, David C Wheeler, Hiddo J Lambers Heerspink
Effect of dapagliflozin on kidney and cardiovascular outcomes by baseline KDIGO risk categories: a post hoc analysis of the DAPA-CKD trial. Diabetologia 65 (7) (2022)
Farsad Afshinnia, Thekkelnaycke M Rajendiran, Chenchen He, Jaeman Byun, Daniel Montemayor, Manjula Darshi, Jana Tumova, Jiwan Kim, Christine P Limonte, Rachel G Miller, Tina Costacou, Trevor J Orchard, Tarunveer S Ahluwalia, Ellen Burgess, Janet K Snell-Bergeon, Ian H de Boer, Loki Natarajan, George Michailidis, Kumar Sharma, Subramaniam Pennathur
Circulating Free Fatty Acid and Phospholipid Signature Predicts Early Rapid Kidney Function Decline in Patients With Type 1 Diabetes. Diabetes care 44 (9) (2021)
Bertram Pitt, Gerasimos Filippatos, Rajiv Agarwal, Stefan D Anker, George L Bakris, Ellen Burgess, Amer Joseph, Peter Kolkhof, Christina Nowack, Patrick Schloemer, Luis M Ruilope, null null
Cardiovascular Events with Finerenone in Kidney Disease and Type 2 Diabetes. The New England journal of medicine 385 (24) (2021)
Emilie H Zobel, Rasmus Sejersten Ripa, Bernt J von Scholten, Viktor Rotbain Curovic, Lars Jorge Diaz, Tine W Hansen, Ellen Burgess, Andreas Kjaer
Effect of Liraglutide on Vascular Inflammation Evaluated by [64Cu]DOTATATE. Diagnostics (Basel, Switzerland) 11 (8) (2021)
Dorte Vistisen, Gregers S Andersen, Adam Hulman, Stuart J McGurnaghan, Helen Martina Colhoun, Jan E Henriksen, Reimar Wernich Thomsen, Frederik Persson, Ellen Burgess, Marit Eika Jorgensen
A Validated Prediction Model for End-Stage Kidney Disease in Type 1 Diabetes. Diabetes care 44 (4) (2021)
Stephen C Bain, Ellen Burgess, Priya Vart, Glenn M Chertow, Fan Fan Hou, Niels Jongs, John Joseph Valentine McMurray, Ricardo Correa-Rotter, Harpreet S Bajaj, Bergur V Stefansson, Robert D Toto, Anna Maria Langkilde, David C Wheeler, Hiddo J Lambers Heerspink, null null
Efficacy and Safety of Dapagliflozin by Baseline Glycemic Status: A Prespecified Analysis From the DAPA-CKD Trial. Diabetes care 44 (8) (2021)
Frederik Persson, Stephen C Bain, Ofri Mosenzon, Hiddo J L Heerspink, Johannes F E Mann, Hiddo J Lambers Heerspink, Itamar Raz, Itamar Raz, Søren Rasmussen, Bernt Johan von Scholten, Ellen Burgess, null null
Changes in Albuminuria Predict Cardiovascular and Renal Outcomes in Type 2 Diabetes: A Post Hoc Analysis of the LEADER Trial. Diabetes care 44 (4) (2021)
Signe Abitz Winther, Miia Maininki Mannerla, Marie Frimodt-Møller, Frederik Persson, Tine Willum Hansen, Markku Lehto, Sohvi Hörkkö, Michael Blaut, Carol Forsblom, Per-Henrik Groop, Ellen Burgess
Faecal biomarkers in type 1 diabetes with and without diabetic nephropathy. Scientific reports 11 (1) (2021)
Ellen Burgess, Marie Frimodt-Møller, Tine Willum Hansen
Linking Kidney and Cardiovascular Complications in Diabetes-Impact on Prognostication and Treatment: The 2019 Edwin Bierman Award Lecture. Diabetes 70 (1) (2021)
Hiddo J L Heerspink, Di Xie, George L Bakris, Ricardo Correa-Rotter, Fan-Fan Hou, Dalane W Kitzman, Donald Kohan, Hirofumi Makino, John J V McMurray, Vlado Perkovic, Ellen Burgess, Hans-Henrik Parving, Dick de Zeeuw, null null
Early Response in Albuminuria and Long-Term Kidney Protection during Treatment with an Endothelin Receptor Antagonist: A Prespecified Analysis from the SONAR Trial. Journal of the American Society of Nephrology : JASN 32 (11) (2021)
Roderick C Slieker, Louise A Donnelly, Hugo Fitipaldi, Gerard A Bouland, Giuseppe N Giordano, Mikael Åkerlund, Mathias J Gerl, Emma Ahlqvist, Ashfaq Ali, Iulian Dragan, Andreas Festa, Michael K Hansen, Dina Mansour Aly, Min Kim, Dmitry Kuznetsov, Florence Mehl, Christian Klose, Kai Simons, Imre Pavo, Timothy J Pullen, Tommi Suvitaival, Asger Wretlind, Ellen Burgess, Valeriya Lyssenko, Cristina Legido-Quigley, Leif C Groop, Bernard Thorens, Paul W Franks, Mark Ibberson, Guy A Rutter, Joline W J Beulens, Leen M 't Hart, Ewan R Pearson
Replication and cross-validation of type 2 diabetes subtypes based on clinical variables: an IMI-RHAPSODY study. Diabetologia 64 (9) (2021)
Dorte Vistisen, Gregers S Andersen, Adam Hulman, Stuart J McGurnaghan, Helen Martina Colhoun, Jan E Henriksen, Reimar Wernich Thomsen, Frederik Persson, Ellen Burgess, Marit Eika Jorgensen
Response to Comment on Vistisen et al. A Validated Prediction Model for End-Stage Kidney Disease in Type 1 Diabetes. Diabetes Care 2021;44:901-907. Diabetes care 44 (6) (2021)
Lesley A Inker, Nwamaka D Eneanya, Josef Coresh, Hocine Tighiouart, Dan Wang, Yingying Sang, Deidra C Crews, Alessandro Doria, Michelle M Estrella, Marc Froissart, Morgan E Grams, Tom Greene, Anders Grubb, Vilmundur Gudnason, Orlando M Gutiérrez, Roberto Kalil, Amy B Karger, Michael Mauer, Gerjan Navis, Robert G Nelson, Emilio D Poggio, Roger Rodby, Ellen Burgess, Andrew D Rule, Elizabeth Selvin, Jesse C Seegmiller, Michael G Shlipak, Vicente E Torres, Wei Yang, Shoshana H Ballew, Sara J Couture, Neil R Powe, Andrew S Levey, null null
New Creatinine- and Cystatin C-Based Equations to Estimate GFR without Race. The New England journal of medicine 385 (19) (2021)
Rajiv Agarwal, Stefan D Anker, Gerasimos Filippatos, Bertram Pitt, Ellen Burgess, Luis M Ruilope, John Boletis, Robert Toto, Guillermo E Umpierrez, Christoph Wanner, Takashi Wada, Charlie Scott, Amer Joseph, Ike Ogbaa, Luke Roberts, Markus F Scheerer, George L Bakris
Effects of canagliflozin versus finerenone on cardiorenal outcomes: exploratory post-hoc analyses from FIDELIO-DKD compared to reported CREDENCE results. Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association (2021)
Ellen Burgess
Mineralocorticoid Receptor Antagonists for Diabetic Kidney Disease. Clinical journal of the American Society of Nephrology : CJASN 15 (12) (2020)
Hiddo J L Heerspink, Bergur V Stefánsson, Ricardo Correa-Rotter, Glenn M Chertow, Tom Greene, Fan-Fan Hou, Johannes F E Mann, John Joseph Valentine McMurray, Magnus Lindberg, Ellen Burgess, C David Sjöström, Roberto D Toto, Anna-Maria Langkilde, David C Wheeler, null null
Dapagliflozin in Patients with Chronic Kidney Disease. The New England journal of medicine 383 (15) (2020)
Gorm Mørk Hansen, Peter Godsk Jørgensen, Henrik Ullits Andersen, Ellen Burgess, Magnus Thorsten Jensen
Relationship between peripheral neuropathy, diastolic function and adverse cardiovascular outcome in individuals with type 1 diabetes mellitus without known cardiovascular disease: Results from the Thousand & 1 Study. Diabetes, obesity & metabolism 23 (1) (2020)
Nete Tofte, Frederik Persson, Ellen Burgess
Omics research in diabetic kidney disease: new biomarker dimensions and new understandings? Journal of nephrology 33 (5) (2020)
George L Bakris, Rajiv Agarwal, Stefan D Anker, Bertram Pitt, Luis M Ruilope, Ellen Burgess, Peter Kolkhof, Christina Nowack, Patrick Schloemer, Amer Joseph, Gerasimos Filippatos, null null
Effect of Finerenone on Chronic Kidney Disease Outcomes in Type 2 Diabetes. The New England journal of medicine 383 (23) (2020)
Jens Christian Laursen, Christian Stevns Hansen, M Bordino, Dorte Vistisen, Emilie H Zobel, Signe Abitz Winther, Per-Henrik Groop, Marie Frimodt-Møller, L Bernardi, Ellen Burgess
Hyperoxia improves autonomic function in individuals with long-duration type 1 diabetes and macroalbuminuria. Diabetic medicine : a journal of the British Diabetic Association 37 (9) (2020)
Signe Abitz Winther, Peter Henriksen, Josef K Vogt, Tue Haldor Hansen, Linda Ahonen, Tommi Suvitaival, Emilie Hein Zobel, Marie Frimodt-Møller, Tine Willum Hansen, Torben Hansen, Hans-Henrik Parving, Cristina Legido-Quigley, Ellen Burgess, Oluf Pedersen
Gut microbiota profile and selected plasma metabolites in type 1 diabetes without and with stratification by albuminuria. Diabetologia 63 (12) (2020)
Alessandro Doria, Andrzej T Galecki, Cathie Spino, Rodica Pop-Busui, David Z Cherney, Ildiko Lingvay, Afshin Parsa, Ellen Burgess, Ronald J Sigal, Maryam Afkarian, Ronnie Aronson, M Luiza Caramori, Jill P Crandall, Ian H de Boer, Thomas G Elliott, Allison B Goldfine, J Sonya Haw, Irl B Hirsch, Amy B Karger, David M Maahs, Janet B McGill, Mark E Molitch, Bruce A Perkins, Sarit Polsky, Marlon Pragnell, William N Robiner, Sylvia E Rosas, Peter Senior, Katherine R Tuttle, Guillermo E Umpierrez, Amisha Wallia, Ruth S Weinstock, Chunyi Wu, Michael Mauer, null null
Serum Urate Lowering with Allopurinol and Kidney Function in Type 1 Diabetes. The New England journal of medicine 382 (26) (2020)
Sankar D Navaneethan, Sophia Zoungas, M Luiza Caramori, Juliana Chung Ngor Chan, Hiddo J Lambers Heerspink, Clint Hurst, Adrian Liew, Erin Donelly Michos, Wasiu A Olowu, Tami Sadusky, Nikhil Tandon, Katherine R Tuttle, Christoph Wanner, Katy G Wilkens, Lyubov Lytvyn, Jonathan C Craig, David J Tunnicliffe, Martin Howell, Marcello Tonelli, Michael Cheung, Amy Earley, Ellen Burgess, Ian H de Boer, Kamlesh Khunti
Diabetes Management in Chronic Kidney Disease: Synopsis of the 2020 KDIGO Clinical Practice Guideline. Annals of internal medicine 174 (3) (2020)
Viktor Rotbain Curovic, Simone Theilade, Signe Abitz Winther, Simone Theilade, Lise Tarnow, Anders Jorsal, Hans-Henrik Parving, Stephen C Bain, Tine Willum Hansen, Ellen Burgess
Visit-to-visit variability of clinical risk markers in relation to long-term complications in type 1 diabetes. Diabetic medicine : a journal of the British Diabetic Association 38 (5) (2020)
Signe Abitz Winther, Simone Theilade, Signe A Winther, Sørine Birkelund, Jens P Goetze, Tine W Hansen, Ellen Burgess
Comparison of Natriuretic Peptides as Risk Markers for All-Cause Mortality and Cardiovascular and Renal Complications in Individuals With Type 1 Diabetes. Diabetes care 44 (2) (2020)
Simone Theilade, Tommi Suvitaival, Linda Ahonen, Signe A Winther, Simone Theilade, Marie Frimodt-Møller, Tarunveer S Ahluwalia, Ellen Burgess
Lipidomic analysis reveals sphingomyelin and phosphatidylcholine species associated with renal impairment and all-cause mortality in type 1 diabetes. Scientific reports 9 (1) (2019)
Ellen Burgess
Subclassification of diabetes based on quantitative traits. Nature reviews. Nephrology 14 (6) (2019)
Jakob Appel Østergaard, Steffen Thiel, I T Hoffmann-Petersen, P Hovind, H-H Parving, Lise Tarnow, Ellen Burgess, Troels Krarup Hansen
Incident microalbuminuria and complement factor mannan-binding lectin-associated protein 19 in people with newly diagnosed type 1 diabetes. Diabetes/metabolism research and reviews 33 (5) (2017)

Ellen Burgess.css-eqlu8i{font-size:small;padding-left:4px;} (P Rossing, Peter Rossing)

Publication Activity (10 Years)

Top Topics

Top Venues

Ellen Burgess (P Rossing, Peter Rossing)